ATI-502 topical solution

ATI-502 topical solution · Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-502 topical solution, covering 2020-02-06 to 2020-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis [Phase 2]